Traduction de «échelle d'évaluation des maladies cumulatives » (Français → Anglais) :

(11) To minimise the public health consequences of cross-border health threats which could range from mass contamination caused by chemical incidents to pandemics, like those unleashed recently by E coli, influenza strain H1N1 or SARS (severe acute respiratory syndrome) or diseases from developing countries which through global population movements are an increasing reality in some European countries, the Programme should contribute to the creation and maintenance of robust mechanisms and tools to detect, assess and manage major cross-border ...[+++]health threats.

18. Criticises the fact that the Commission has failed to pay sufficient attention to the gender mainstreaming approach when dealing with issues concerning health and safety at work, either in the Community strategy on health and safety at work or in its mid-term assessment; supports therefore the initiative of the Commission calling for the preparation of unique methods of impact assessment in OSH with regard to gender specificity; calls on the Commission to assess the availability of gender-disaggregated statistics at Community level on work-related fatal and non-fatal diseases; encourages the Member States to take into consideration the special risks female workers are facing in preventive policies ...[+++] and risk assessment methods;

(c) establishing Member States' assessment reports on the clinical added value of orphan drugs at EU level within the European Medicines Agency (EMEA) where the relevant European knowledge and expertise is gathered , in order to minimise delays for access to orphan drugs for rare disease patients;

(c) establishing Member States' assessment reports on the clinical added value of orphan drugs at EU level within the EMEA where the relevant European knowledge and expertise is gathered, in order to minimise delays for access to orphan drugs for rare disease patients;

Identifying diabetes as a public health challenge in Europe and encouraging networking and the exchange of information between Member States with a view to promoting best practices, to enhancing the co-ordination of health promotion and prevention policies and programmes for the whole population and high-risk groups and to reducing inequalities and optimising healthcare resources; Facilitating and supporting European diabetes research in basic and clinical science and ensuring the wide dissemination of the results of this research across Europe; Examini ...[+++]ng and strengthening the comparability of diabetes epidemiological evidence by considering the establishment of standardised outputs for monitoring, surveillance and reporting of diabetes mortality, morbidity and risk factor data across Member States; Reporting on Member States' actions in order to emphasise health determinants, promote healthy lifestyles, national diabetes plans and prevention measures, on the basis of information provided by Member States, assessing the extent to which the proposed measures are working effectively, and considering the need for further action; Continuing the work on the development of a comprehensive approach to health determinants at European level, including a coherent and comprehensive nutrition and physical activity policy, and addressing the impact on public health of the promotion, marketing and presentation, in particular to children, of energy dense foods and sugar-sweetened drinks; Building on the work of the EU Platform for Action on Diet, Physical Activity and Health and encouraging the development and implementation of national diabetes prevention programmes and measures; Taking the health determinants and risk factors of diabetes into account across EU policies.

The Branch works with stakeholders at all levels to: provide national and international leadership in health promotion, chronic disease prevention and control; coordinate the surveillance of chronic diseases and their risk factors and early disease detection; create and evaluate/measure programs addressing common risk factors and specialized issues focussing on special populations (seniors, children).